NVSEF
Price
$115.50
Change
+$0.25 (+0.22%)
Updated
Jul 25 closing price
Capitalization
216.52B
ORINY
Price
$41.50
Change
-$0.00 (-0.00%)
Updated
Jul 25 closing price
Capitalization
5.42B
Interact to see
Advertisement

NVSEF vs ORINY

Header iconNVSEF vs ORINY Comparison
Open Charts NVSEF vs ORINYBanner chart's image
Novartis AG
Price$115.50
Change+$0.25 (+0.22%)
Volume$110
Capitalization216.52B
Orion Corporation OY
Price$41.50
Change-$0.00 (-0.00%)
Volume$525
Capitalization5.42B
NVSEF vs ORINY Comparison Chart in %
Loading...
NVSEF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORINY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NVSEF vs. ORINY commentary
Jul 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NVSEF is a StrongBuy and ORINY is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 28, 2025
Stock price -- (NVSEF: $115.50 vs. ORINY: $41.50)
Brand notoriety: NVSEF and ORINY are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: NVSEF: 1% vs. ORINY: 235%
Market capitalization -- NVSEF: $216.52B vs. ORINY: $5.42B
NVSEF [@Pharmaceuticals: Major] is valued at $216.52B. ORINY’s [@Pharmaceuticals: Major] market capitalization is $5.42B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NVSEF’s FA Score shows that 2 FA rating(s) are green whileORINY’s FA Score has 3 green FA rating(s).

  • NVSEF’s FA Score: 2 green, 3 red.
  • ORINY’s FA Score: 3 green, 2 red.
According to our system of comparison, ORINY is a better buy in the long-term than NVSEF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NVSEF’s TA Score shows that 5 TA indicator(s) are bullish while ORINY’s TA Score has 4 bullish TA indicator(s).

  • NVSEF’s TA Score: 5 bullish, 4 bearish.
  • ORINY’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, NVSEF is a better buy in the short-term than ORINY.

Price Growth

NVSEF (@Pharmaceuticals: Major) experienced а -2.70% price change this week, while ORINY (@Pharmaceuticals: Major) price change was +6.75% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +3.43%. For the same industry, the average monthly price growth was +7.37%, and the average quarterly price growth was +13.00%.

Industries' Descriptions

@Pharmaceuticals: Major (+3.43% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NVSEF($217B) has a higher market cap than ORINY($5.42B). NVSEF has higher P/E ratio than ORINY: NVSEF (29.50) vs ORINY (17.06). ORINY YTD gains are higher at: 91.928 vs. NVSEF (20.187). NVSEF has higher annual earnings (EBITDA): 17.8B vs. ORINY (390M). NVSEF has more cash in the bank: 11.2B vs. ORINY (74.6M). ORINY has less debt than NVSEF: ORINY (207M) vs NVSEF (28.3B). NVSEF has higher revenues than ORINY: NVSEF (53.1B) vs ORINY (1.35B).
NVSEFORINYNVSEF / ORINY
Capitalization217B5.42B4,001%
EBITDA17.8B390M4,564%
Gain YTD20.18791.92822%
P/E Ratio29.5017.06173%
Revenue53.1B1.35B3,922%
Total Cash11.2B74.6M15,013%
Total Debt28.3B207M13,671%
FUNDAMENTALS RATINGS
NVSEF vs ORINY: Fundamental Ratings
NVSEF
ORINY
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
31
Undervalued
PROFIT vs RISK RATING
1..100
3614
SMR RATING
1..100
2925
PRICE GROWTH RATING
1..100
5338
P/E GROWTH RATING
1..100
8349
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NVSEF's Valuation (15) in the null industry is in the same range as ORINY (31). This means that NVSEF’s stock grew similarly to ORINY’s over the last 12 months.

ORINY's Profit vs Risk Rating (14) in the null industry is in the same range as NVSEF (36). This means that ORINY’s stock grew similarly to NVSEF’s over the last 12 months.

ORINY's SMR Rating (25) in the null industry is in the same range as NVSEF (29). This means that ORINY’s stock grew similarly to NVSEF’s over the last 12 months.

ORINY's Price Growth Rating (38) in the null industry is in the same range as NVSEF (53). This means that ORINY’s stock grew similarly to NVSEF’s over the last 12 months.

ORINY's P/E Growth Rating (49) in the null industry is somewhat better than the same rating for NVSEF (83). This means that ORINY’s stock grew somewhat faster than NVSEF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NVSEFORINY
RSI
ODDS (%)
Bullish Trend 3 days ago
53%
Bearish Trend 3 days ago
42%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
63%
Bearish Trend 3 days ago
38%
Momentum
ODDS (%)
Bearish Trend 3 days ago
47%
Bullish Trend 3 days ago
56%
MACD
ODDS (%)
Bearish Trend 3 days ago
36%
Bullish Trend 3 days ago
28%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
48%
Bullish Trend 3 days ago
30%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
49%
Bullish Trend 3 days ago
33%
Advances
ODDS (%)
Bullish Trend 3 days ago
53%
Bullish Trend 5 days ago
76%
Declines
ODDS (%)
Bearish Trend 13 days ago
42%
N/A
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
50%
Bearish Trend 3 days ago
36%
Aroon
ODDS (%)
Bullish Trend 3 days ago
46%
Bullish Trend 3 days ago
36%
View a ticker or compare two or three
Interact to see
Advertisement
NVSEF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORINY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PFFD19.110.04
+0.21%
Global X US Preferred ETF
PJBF61.63N/A
N/A
PGIM Jennison Better Future ETF
AVDS64.07-0.09
-0.13%
Avantis International Small Cp Eq ETF
LEMB40.44-0.10
-0.25%
iShares JP Morgan EM Local Ccy Bd ETF
USAF26.55-0.09
-0.33%
Atlas America Fund

NVSEF and

Correlation & Price change

A.I.dvisor tells us that NVSEF and SNYNF have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NVSEF and SNYNF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVSEF
1D Price
Change %
NVSEF100%
+0.22%
SNYNF - NVSEF
26%
Poorly correlated
+4.11%
GIKLY - NVSEF
7%
Poorly correlated
N/A
KYKOF - NVSEF
5%
Poorly correlated
N/A
OPHLY - NVSEF
2%
Poorly correlated
-0.82%
GLAXF - NVSEF
1%
Poorly correlated
+0.90%
More

ORINY and

Correlation & Price change

A.I.dvisor tells us that ORINY and OPHLY have been poorly correlated (+6% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ORINY and OPHLY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORINY
1D Price
Change %
ORINY100%
N/A
OPHLY - ORINY
6%
Poorly correlated
-0.82%
GIKLY - ORINY
4%
Poorly correlated
N/A
GLAXF - ORINY
3%
Poorly correlated
+0.90%
MAYNF - ORINY
2%
Poorly correlated
N/A
NVSEF - ORINY
1%
Poorly correlated
+0.22%
More